q&more
My watch list
my.chemie.de  
Login  

Author

Prof. Dr. Adrian T. Press

Universitätsklinikum Jena - Klinik für Anästhesiologie und Intensivmedizin

Medienzentrum UKJ

Jun.-Prof. Dr. rer. nat. Adrian T. Press

Adrian Press, born in 1989, studied molecular medicine for his bachelor’s and master’s degrees at Furtwangen and the Friedrich Schiller University in Jena, Germany. He then obtained his doctoral degree at the medical faculty in Jena researching novel theranostic nanoparticles. During his postdoc, he specialized in researching biophotonic technologies to characterize and model septic organ failure and translate this knowledge to generate novel personalized therapeutics and diagnostics. After research internships at the Janelia Research Campus of the Howard Hughes Medical Institute in Ashburn, USA, the Tokyo University of Science and Technology and the Innovation Center of NanoMedicine (iCONM), Japan, Lund University, Sweden, and Zhejiang University, PR China till 2020 he accepted the call for a position as Junior Professor at the Friedrich Schiller University for Molecular Medicine of Life-Threatening Infection.

Activities

Junior Professor Dr. Press is an active member of the Society for Biochemistry and Molecular Biology in Germany.

Awards

In 2010, Press received the award of the state of Baden-Württemberg for outstanding academic performance and in 2013 the award from Furtwangen University for the excellence of his bachelor thesis. In the same year, he and his colleagues were awarded the silver medal at the iENA for inventing new, targeted nanoparticles. In 2018 Press received the award as part of the LaserLab Europe (Horizon 2020) for a project to research 2D polarization microscopy to detect cytoskeletal changes in tissues.

Focus

The focus of Press is the research into the molecular mechanisms and the establishment of nanomedicine in life-threatening infections. For this purpose, the group combines molecular techniques with cutting-edge multimodal imaging. Correlating both technologies allows them to investigate molecular events in and between cells and their consequences for the disease and pharmaceutical interventions through nanomedicines. Another focus is on researching the mechanisms of new nanoparticles for use in infections and their interaction with cells and tissues to increase their selectivity and minimize side effects even under the most severe conditions.

Methods

  • Molecular biology, cell biology
  • Animal models
  • Preclinical imaging
  • Highly parallel host response screening

Facts, background information, dossiers

  • molecular medicine
  • infections
  • sepsis
  • biophotonics
  • nanomedicine
  • targeted nanoparticles
  • molecular biology
  • cell biology
  • animal models
  • preclinical imaging
  • parallel screening

Other articles by this author

All articles

Effective drug navigation in sepsis

Many drug candidates never reach clinical use due to their side effects. For example, inhibitors of phosphoinositide 3-kinase-γ, a signaling protein that plays an important role in (…)

More about Universitätsklinikum Jena - KAI

  • q&more articles

    Effective drug navigation in sepsis

    Many drug candidates never reach clinical use due to their side effects. For example, inhibitors of phosphoinositide 3-kinase-γ, a signaling protein that plays an important role in infections, cannot be used because of their side effects on the immune response. more

  • Authors

    Prof. Dr. Michael Bauer

    Michael Bauer, born in 1963, is Professor and Chair of Anesthesiology and Intensive Care and chief executive director of the Center for Sepsis Control Care (CSCC) at University Hospital Jena, Germany. He received his M.D. from Saarland University and postgraduate training in molecular biolo ... more

q&more – the networking platform for quality excellence in lab and process

The q&more concept is to increase the visibility of recent research and innovative solutions, and support the exchange of knowledge. In the broad spectrum of subjects covered, the focus is on achieving maximum quality in highly innovative sectors. As a modern knowledge platform, q&more offers market participants one-of-a-kind networking opportunities. Cutting-edge research is presented by authors of international repute. Attractively presented in a high-quality context, and published in German and English, the original articles introduce new concepts and highlight unconventional solution strategies.

> more about q&more

q&more is supported by:

 

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE